BioSpace News Archive

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”) announces that a total of 3,931 common shares will be issued at the rate of $0.58 per share to satisfy the maintenance fee of $2,280 owing in respect of the debentures issued on April 9, 2019.

IRADIMED CORPORATION announced that the Company will release its 2021 first quarter financial results before the market opens on Friday, April 30th.

DeltEx DRI CAR-T cells are gamma-delta T cells engineered with a Chlorotoxin CAR-T binding domain and a chemotherapy resistance gene, which enhances binding to tumor cells and survival of concomitant dosing with alkylating chemotherapies, such as temazolomide, or TMZ.

Lannett Company, Inc. announced the pricing of the $350 million aggregate principal amount of 7.75% senior secured notes due 2026 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.

Bausch Health Companies Inc. will release its first-quarter 2021 financial results on Tuesday, May 4, 2021. Bausch Health will host a conference call and live web cast at 8:00 a.m. EDT to discuss the results and provide a business update.

CureVac N.V. (Nasdaq:CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid will report financial results and business updates for the fourth quarter and Full-Year of 2020 on Thursday, April 15, 2021.

Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today reprised initial clinical results from its ongoing Phase 1/2 study of RTX-240 in advanced solid tumors at the American Association for Cancer Research (AACR) Virtual Annual Meeting.

Dental braces are commonly used in orthodontist treatment in order to fix malocclusion and jaw problems. Dental braces are used for providing proper alignment to teeth; they are custom-based devices used for keeping pressure on the teeth to straighten them over a period of time.

Medication adherence is and umbrella term for systems used to upgrade adaptation to endorsed drugs.

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the initiation of patient dosing in UPLIFT, a single-arm registration strategy to evaluate the safety and efficacy of upifitamab rilsodotin (UpRi, XMT-1536) in patients with platinum-resistant ovarian cancer